This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Decoding Interstitial Lung Disease: Identifying and Managing Progressive Phenotypes

Decoding Interstitial Lung Disease: Identifying and Managing Progressive Phenotypes



Time to Complete

1 hour


May 24, 2019


May 24, 2020
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider

This activity is provided by Penn State College of Medicine.

Commercial Supporter

Supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Program Description

Interstitial lung disease (ILD) comprises more than 130 distinct lung disorders. Some forms of ILD, including connective tissue disease-associated ILD (CTD-ILD), chronic hypersensitivity pneumonitis (CHP), and fibrosing types of ILD such as fibrotic nonspecific interstitial pneumonia (fNSIP), follow a particularly aggressive course. This activity will address the timely identification and treatment of these progressive phenotypes.

Intended Audience

Physicians, nurse practitioners (NPs), and physician assistant (PAs) specializing in pulmonology, radiology, pathology, rheumatology, or primary care/internal medicine.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Identify and monitor patients who are at increased risk for ILD with a progressive phenotype.
  • Describe the pathophysiology of ILD with a progressive phenotype.
  • In patients at risk for having a progressive phenotype, recognize the signs and symptoms of ILD.
  • Develop a management strategy for patients with ILD with a progressive phenotype.

Conflict Of Interest Disclosure Policy

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest.


Sonye K. Danoff, MD, PhD
Associate Professor of Medicine
Co-Director, Johns Hopkins ILD/IPF Program
Associate Director
Johns Hopkins Myositis Center
Baltimore, MD

Dr. Danoff has disclosed the following:
Grant/research support: Boehringer Ingelheim, Bristol-Myers Squibb
Consultant: Boehringer Ingelheim, Galapagos NV, Trevi Therapeutics


Imre Noth, MD
Chief, Division of Pulmonary and Critical Care Medicine
Dudley F. Rochester
Endowed Professor Of Medicine
University of Virginia
Charlottesville, VA

Dr. Noth has disclosed the following:
Consultant: Boehringer Ingelheim, Roche/Genentech, Immuneworks
Speakers bureau: Boehringer Ingelheim

Mary E. Strek, MD
Professor of Medicine
Director, University of Chicago
Interstitial Lung Disease Program
Chair, Pulmonary Fibrosis Foundation
Clinical Care Network Registry Ancillary Studies Committee
Chicago, IL

Dr. Strek has disclosed the following:
Grant/research support: Boehringer Ingelheim, Novartis
Consultant: Boehringer Ingelheim
Speakers bureau: Boehringer Ingelheim

Accredited Provider Disclosure

Penn State staff involved in the development and review of this activity have nothing to disclose.

Publishing Staff Disclosure

MCM Education staff involved in the development and review of this activity have nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and MCM Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Penn State College of Medicine designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

Faculty members are required to inform the audience when they are discussing off-label or unapproved uses of devices or drugs. Devices or drugs that are still undergoing clinical trials are identified as such and should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling.


The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions; the publisher; Penn State College of Medicine; or Boehringer Ingelheim Pharmaceuticals, Inc. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.


To obtain credit, a score of 80% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

For questions regarding CME credit, contact Penn State Continuing Education at 717-531-6483 or Please reference activity code G6321-19-T.


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue